Is Cas13-based 4R-tau silencing feasible given collateral cleavage risks in post-mitotic neurons?
Cas13 gRNA Design for Silencing MAPT (Tau) Transcripts in Alzheimer's Disease
Computing debate synthesis…
📊 Community Betting Market
Loading market data…
Debate Transcript
No transcript rounds recorded for this debate.